trending Market Intelligence /marketintelligence/en/news-insights/trending/5uarzswsh6oqalxkh4igea2 content esgSubNav
In This List

Jubilant Pharma director resigns

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Jubilant Pharma director resigns

Inder Verma stepped down as a director of Jubilant Pharma Ltd.

The resignation is effective Aug. 6.